Robert Bruce Boxer, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Teaching Rounds | 2 | 2021 | 280 | 0.540 |
Why?
|
| Aftercare | 2 | 2023 | 911 | 0.490 |
Why?
|
| Medical Staff, Hospital | 2 | 2019 | 601 | 0.440 |
Why?
|
| Patient Discharge | 5 | 2023 | 3461 | 0.440 |
Why?
|
| Efficiency, Organizational | 1 | 2017 | 697 | 0.400 |
Why?
|
| Patient Care Planning | 1 | 2016 | 906 | 0.350 |
Why?
|
| Mammary Neoplasms, Experimental | 4 | 2007 | 498 | 0.340 |
Why?
|
| Lactation | 3 | 2012 | 391 | 0.330 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2006 | 185 | 0.260 |
Why?
|
| Patient Care Team | 1 | 2017 | 2517 | 0.250 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2012 | 2453 | 0.250 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2006 | 995 | 0.230 |
Why?
|
| Academic Medical Centers | 4 | 2019 | 2780 | 0.230 |
Why?
|
| Mammary Glands, Animal | 4 | 2012 | 272 | 0.210 |
Why?
|
| Communication | 2 | 2017 | 3916 | 0.200 |
Why?
|
| STAT5 Transcription Factor | 2 | 2012 | 269 | 0.180 |
Why?
|
| Respiration Disorders | 1 | 2022 | 362 | 0.160 |
Why?
|
| Telemetry | 1 | 2019 | 201 | 0.150 |
Why?
|
| Cardiology Service, Hospital | 1 | 2019 | 242 | 0.140 |
Why?
|
| Electronic Health Records | 3 | 2020 | 4873 | 0.140 |
Why?
|
| Patient Readmission | 5 | 2023 | 3286 | 0.140 |
Why?
|
| Respiratory Tract Diseases | 1 | 2022 | 744 | 0.140 |
Why?
|
| Physician-Nurse Relations | 1 | 2016 | 20 | 0.130 |
Why?
|
| Home Care Services | 1 | 2022 | 660 | 0.120 |
Why?
|
| Lipids | 1 | 2006 | 3315 | 0.120 |
Why?
|
| Glucose | 1 | 2006 | 4335 | 0.120 |
Why?
|
| Medical Order Entry Systems | 1 | 2019 | 521 | 0.110 |
Why?
|
| Heart Failure | 3 | 2023 | 11840 | 0.110 |
Why?
|
| Neurology | 1 | 2021 | 785 | 0.110 |
Why?
|
| Inpatients | 3 | 2023 | 2564 | 0.100 |
Why?
|
| Patient Admission | 1 | 2019 | 1365 | 0.100 |
Why?
|
| Isoenzymes | 2 | 2006 | 1689 | 0.100 |
Why?
|
| Pandemics | 2 | 2021 | 8703 | 0.090 |
Why?
|
| User-Computer Interface | 1 | 2017 | 1405 | 0.090 |
Why?
|
| Interprofessional Relations | 1 | 2017 | 999 | 0.090 |
Why?
|
| Prolactin | 1 | 2012 | 625 | 0.090 |
Why?
|
| Adenocarcinoma | 2 | 2004 | 6364 | 0.080 |
Why?
|
| Internal Medicine | 1 | 2017 | 1064 | 0.080 |
Why?
|
| Comprehension | 1 | 2015 | 638 | 0.080 |
Why?
|
| Education, Medical, Graduate | 1 | 2021 | 2418 | 0.080 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 3 | 2006 | 1761 | 0.080 |
Why?
|
| Caregivers | 1 | 2020 | 2307 | 0.070 |
Why?
|
| Quality Improvement | 1 | 2023 | 3853 | 0.070 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 2007 | 68 | 0.070 |
Why?
|
| Hospitalization | 2 | 2023 | 10808 | 0.070 |
Why?
|
| Wnt1 Protein | 1 | 2006 | 120 | 0.070 |
Why?
|
| Mice, Transgenic | 5 | 2007 | 9550 | 0.060 |
Why?
|
| Female | 17 | 2023 | 396112 | 0.060 |
Why?
|
| Patient Education as Topic | 1 | 2015 | 2334 | 0.060 |
Why?
|
| Physicians | 1 | 2022 | 4588 | 0.060 |
Why?
|
| Protein Transport | 2 | 2007 | 1939 | 0.060 |
Why?
|
| Doxycycline | 2 | 2007 | 349 | 0.060 |
Why?
|
| Time Factors | 4 | 2019 | 40065 | 0.060 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 3413 | 0.060 |
Why?
|
| Milk | 1 | 2006 | 436 | 0.060 |
Why?
|
| Asthma | 1 | 2022 | 6270 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2004 | 610 | 0.050 |
Why?
|
| Aged | 6 | 2023 | 171117 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2004 | 1546 | 0.050 |
Why?
|
| Male | 9 | 2023 | 363698 | 0.050 |
Why?
|
| Quality of Health Care | 1 | 2017 | 4300 | 0.050 |
Why?
|
| Length of Stay | 1 | 2016 | 6485 | 0.050 |
Why?
|
| ras Proteins | 2 | 2004 | 1053 | 0.050 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 5508 | 0.050 |
Why?
|
| Humans | 17 | 2023 | 765968 | 0.050 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 7875 | 0.050 |
Why?
|
| Milk Proteins | 2 | 2012 | 161 | 0.040 |
Why?
|
| Retroviridae Infections | 1 | 2001 | 149 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2007 | 2844 | 0.040 |
Why?
|
| Precancerous Conditions | 1 | 2007 | 976 | 0.040 |
Why?
|
| Hospitals, Community | 1 | 2022 | 363 | 0.040 |
Why?
|
| Hospitals | 2 | 2023 | 3888 | 0.040 |
Why?
|
| Mice | 8 | 2012 | 81819 | 0.040 |
Why?
|
| Middle Aged | 5 | 2022 | 223009 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2007 | 8611 | 0.040 |
Why?
|
| Remission Induction | 1 | 2004 | 2411 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2004 | 1505 | 0.040 |
Why?
|
| Tumor Virus Infections | 1 | 2001 | 440 | 0.040 |
Why?
|
| Boston | 2 | 2021 | 9338 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2004 | 4108 | 0.030 |
Why?
|
| Models, Animal | 1 | 2002 | 2120 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2010 | 14448 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2007 | 3681 | 0.030 |
Why?
|
| Retrospective Studies | 5 | 2023 | 81514 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 11888 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2004 | 6832 | 0.030 |
Why?
|
| Adult | 4 | 2022 | 223044 | 0.030 |
Why?
|
| Organizational Culture | 1 | 2017 | 514 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2016 | 41649 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2023 | 59489 | 0.030 |
Why?
|
| Animals | 8 | 2012 | 168764 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2017 | 54802 | 0.020 |
Why?
|
| Recurrence | 1 | 2004 | 8501 | 0.020 |
Why?
|
| Acute Disease | 1 | 2022 | 7232 | 0.020 |
Why?
|
| Mammary Tumor Virus, Mouse | 2 | 2002 | 41 | 0.020 |
Why?
|
| Autocrine Communication | 1 | 2012 | 167 | 0.020 |
Why?
|
| Nurses | 1 | 2021 | 2505 | 0.020 |
Why?
|
| Research | 1 | 2020 | 1975 | 0.020 |
Why?
|
| Transgenes | 2 | 2006 | 1015 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 1509 | 0.020 |
Why?
|
| Signal Transduction | 3 | 2010 | 23601 | 0.020 |
Why?
|
| Public Health | 1 | 2023 | 2680 | 0.020 |
Why?
|
| Health Literacy | 1 | 2015 | 464 | 0.020 |
Why?
|
| Janus Kinases | 1 | 2010 | 253 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2021 | 3475 | 0.020 |
Why?
|
| Apoptosis | 1 | 2004 | 9514 | 0.020 |
Why?
|
| Critical Care | 1 | 2021 | 2712 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2001 | 4520 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2010 | 788 | 0.020 |
Why?
|
| Patient Participation | 1 | 2017 | 1455 | 0.020 |
Why?
|
| Continuity of Patient Care | 1 | 2015 | 1078 | 0.020 |
Why?
|
| Health Status Disparities | 1 | 2019 | 1880 | 0.020 |
Why?
|
| Quality Indicators, Health Care | 1 | 2017 | 1806 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2012 | 1119 | 0.020 |
Why?
|
| Mutation | 3 | 2007 | 30198 | 0.020 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2007 | 130 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2007 | 2942 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2012 | 2927 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2012 | 2666 | 0.010 |
Why?
|
| Cell Differentiation | 2 | 2012 | 11641 | 0.010 |
Why?
|
| Hyperplasia | 1 | 2007 | 1144 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2007 | 703 | 0.010 |
Why?
|
| Cell Proliferation | 2 | 2010 | 10429 | 0.010 |
Why?
|
| Internet | 1 | 2015 | 3106 | 0.010 |
Why?
|
| Receptors, Progesterone | 1 | 2007 | 1153 | 0.010 |
Why?
|
| Terminal Repeat Sequences | 1 | 2002 | 70 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2006 | 1240 | 0.010 |
Why?
|
| Ornithine Decarboxylase | 1 | 2001 | 63 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2002 | 572 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 2002 | 696 | 0.010 |
Why?
|
| Cell Survival | 1 | 2010 | 5747 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2006 | 3586 | 0.010 |
Why?
|
| Internship and Residency | 1 | 2019 | 5946 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2007 | 2242 | 0.010 |
Why?
|
| Genes, ras | 1 | 2001 | 658 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2019 | 24282 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2007 | 4137 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2002 | 1524 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2012 | 18973 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2001 | 1228 | 0.010 |
Why?
|
| Pregnancy | 2 | 2012 | 30260 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2002 | 1744 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2007 | 5786 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2007 | 3430 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 10729 | 0.010 |
Why?
|
| United States | 1 | 2022 | 72903 | 0.010 |
Why?
|
| Kinetics | 1 | 2002 | 6274 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 65188 | 0.010 |
Why?
|
| Risk Factors | 1 | 2019 | 74840 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2002 | 2850 | 0.010 |
Why?
|
| RNA | 1 | 2002 | 2717 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2001 | 2880 | 0.010 |
Why?
|
| Proteins | 1 | 2001 | 5995 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 2001 | 12768 | 0.000 |
Why?
|